Health ❯ Healthcare ❯ Regulatory Agencies

Anvisa

Drug Approval Product Safety Drug Regulations Product Prohibition Drug Monitoring Drug Regulation Drug Approval Process Vaccine Approval Process Product Compliance Product Recall

Brazil Approves Yesintek as a Stelara Biosimilar for Autoimmune Diseases

The move could lower treatment costs by adding competition.

Brazil Approves Local Production of Butantan Chikungunya Vaccine as São Paulo Expands Dengue Shots to 59-Year-Olds

Brazil Bans All Medicines With Clobutinol Over Cardiac Risk

Anvisa Rejects Three Semaglutide and Liraglutide Drug Filings in Brazil

Brazil Cracks Down on Illegal GLP-1 Weight‑Loss Injections as Anvisa Tightens Oversight

Fiocruz Flags Rising Influenza A and Severe Respiratory Cases Across Brazil

Anvisa Issues Safety Alert on Misuse of Dermal Fillers in Brazil

Anvisa Logs 65 Suspected Deaths Linked to GLP-1 Weight-Loss Injections in Brazil

Anvisa Issues Safety Alert on GLP‑1 Injection Pens After Six Suspected Pancreatitis Deaths in Brazil

Brazil Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

Anvisa Orders Lot-Specific Recalls Over Packaging Mix-Ups, Seizes Falsified Drug Batches

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

Anvisa Orders Recall of Hypofarma Furosemide Batch Over Glass-Like Material